1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2015 Strategies in the German Hepatitis Diagnostic Testing Market

2015 Strategies in the German Hepatitis Diagnostic Testing Market

  • May 2015
  • -
  • Venture Planning Group
  • -
  • 241 pages

Complete report $3,900.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.

The report presents a detailed analysis of the Hepatitis diagnostics market in
Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.  The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals                                                                              
     - Commercial/Private Labs
     - Blood Banks


In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
                                                                                                    
Contains 241 pages and 14 tables

The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

Table Of Contents

2015 Strategies in the German Hepatitis Diagnostic Testing Market
I. Introduction
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 Classification
0 Transmission of Infection
0 Occupational Hazards
0 Acute Hepatitis
0 Diagnosis of Acute Infection
0 Chronic Hepatitis
0 HCV and Other Chronic Liver Diseases
0 Alcoholic Liver Disease
0 Hepatitis B Coinfection
0 Cirrhosis and Hepatocellular Carcinoma
0 Diagnostic Tests
0 Possible Indications for HCV RNA Testing
0 Conclusions and Future Direction
E. Hepatitis D
0 Historical Perspective
0 Epidemiology
0 HBV-HDV "Coinfection" vs. "Superinfection"
0 Methods of Detecting HDV
0 Prevention
F. Hepatitis E
0 Background
0 Prevalence of the Disease
0 Diagnostic Tests
0 Epidemiologic Serosurveys
0 Serologic Cross-Reactivity
G. Hepatitis G
0 Vaccines and Drugs

H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics/Grifols
- Ortho-Clinical Diagnostics
- Qiagen
- Roche

- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables
Major Companies Developing or Marketing Hepatitis Tests
Germany
HAV NAT Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
HBV NAT Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
HBs Ag Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Hepatitis C Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Anti-HBc Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Anti-HBs Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Anti-HAV Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Hepatitis Delta Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
HBc Ag Test Volume and Diagnostics Sales Forecast
By Market Segment

Germany
HBe Ag Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
ALT/SGPT Test Volume and Diagnostics Sales Forecast
By Market Segment
Germany
Hepatitis Testing Market Diagnostics Sales
By Major Supplier
Germany
Hepatitis C Testing Market Diagnostics Sales
By Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...

2017-2021 Hepatitis Diagnostic Testing Market

2017-2021 Hepatitis Diagnostic Testing Market

  • $ 6250
  • Industry report
  • February 2017
  • by Venture Planning Group

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology ...

2017-2021 World Hepatitis Diagnostics Market: Emerging Opportunities and Growth Strategies

2017-2021 World Hepatitis Diagnostics Market: Emerging Opportunities and Growth Strategies

  • $ 6250
  • Industry report
  • February 2017
  • by Venture Planning Group

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.